Abstract
In the interests of the safety of patients it is necessary to collect long-term clinical data. It is often assumed that the longer the trial the better. However, the longer the trial the more scientific compromises are necessary if it is to be carried out in a practical way. Because the therapeutic efficacy of and tolerance to the nonsteroidal anti-inflammatory drug diclofenac was established after 6 months' trial the optimal duration for a comparative long-term trial of this preparation is 6 months. The small amount of information gained from trials of diclofenac longer than this did not justify the reduction in quality of trial design and performance that they required. Thus it would appear that at least for 1 antirheumatic drug the assumption that 'the longer the trial the better' is not true.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abrams G. J., Solomon L., Meyers O. L. A long-term study of diclophenac sodium in the treatment of rheumatoid arthritis and osteo-arthrosis. S Afr Med J. 1978 Mar 25;53(12):442–445. [PubMed] [Google Scholar]
- Bijlsma A. The long-term efficacy and tolerability of Voltaren (diclofenac sodium) and indomethacin in rheumatoid arthritis. Scand J Rheumatol Suppl. 1978;(22):74–80. doi: 10.3109/03009747809097221. [DOI] [PubMed] [Google Scholar]
- Ciccolunghi S. N., Chaudri H. A., Schubiger B. I., Reddrop R. Report on a long-term tolerability study of up to two years with diclofenac sodium (Voltaren). Scand J Rheumatol Suppl. 1978;(22):86–96. doi: 10.3109/03009747809097223. [DOI] [PubMed] [Google Scholar]
- Miura T. Long-term tolerability study of Voltaren. J Int Med Res. 1975;3(3):145–152. doi: 10.1177/030006057500300302. [DOI] [PubMed] [Google Scholar]